Trials / Completed
CompletedNCT05526300
Intelligent Hypertension Intervention Study
Randomized Study of Antihypertensive Intervention by Intelligent Hypertension Management System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 320 (actual)
- Sponsor
- Shanghai Tong Ren Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To explore whether the application of intelligent hypertension management system can effectively reduce blood pressure in hypertensive patients. A total of 320 eligible subjects will be recruited and randomization to two groups. The standard care group (n=160) will receive conventional hypertension treatment with baseline data collected.Wearable blood pressure monitoring device management group (intervention group, n=160) will receive blood pressure monitoring remotely everyday and antihypertension medication treatment. Primary outcome is Net change in systolic blood pressure from baseline to 3 months follow-up. Secondary outcomes include Net change in diastolic blood pressure hypertension control ratio (BP \< 140/90 mmHg)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Intelligent Hypertension Management System | The intelligent hypertension management system is used to remotely detect the blood pressure of hypertensive patients |
| OTHER | The standard care | The standard care |
Timeline
- Start date
- 2022-09-06
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
- First posted
- 2022-09-02
- Last updated
- 2025-05-21
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05526300. Inclusion in this directory is not an endorsement.